Renalytix plc (LSE: RENX, OTCQB: RNLXY)*: Three kidneyintelX.dkd clinical integration – update on Tempus collaboration Futura Medical plc (AIM: FUM): Positive results from WSD4000 early feasibility study
12 Jan 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Futura Medical plc (FUM:LON), 1.3 | Renalytix Plc (RENX:LON), 5.8
- Published:
12 Jan 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
3 -
Renalytix plc (LSE: RENX, OTCQB: RNLXY)*: Three kidneyintelX.dkd clinical integration – update on Tempus collaboration Futura Medical plc (AIM: FUM): Positive results from WSD4000 early feasibility study